Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis

BACKGROUND: Plaque psoriasis is a debilitating skin condition that affects approximately 2% of the adult population and for which there is currently no cure. Tofacitinib is an oral Janus kinase inhibitor that is being investigated for psoriasis. METHODS: The design of this study has been reported pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Valenzuela, Fernando, Papp, Kim A, Pariser, David, Tyring, Stephen K, Wolk, Robert, Buonanno, Marjorie, Wang, Jeff, Tan, Huaming, Valdez, Hernan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436155/
https://www.ncbi.nlm.nih.gov/pubmed/25951857
http://dx.doi.org/10.1186/s12895-015-0025-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436155/
https://www.ncbi.nlm.nih.gov/pubmed/25951857
http://dx.doi.org/10.1186/s12895-015-0025-y

Ejemplares similares